Aspirin as antiplatelet agent in diabetes: Cons

European Journal of Internal Medicine

Volumn 21, Issue 3, 2010, Pages 154-156

  Mannucci, P M ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; PICOTAMIDE; PRASUGREL; SCH 530398; TICAGRELOR; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ANTICOAGULANT THERAPY; ARTERY DISEASE; ARTERY THROMBOSIS; ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; HEART INFARCTION; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PRIMARY PREVENTION; RISK REDUCTION; SECONDARY PREVENTION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS PREVENTION;

EID: 77952293602     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2010.03.009     Document Type: Note

References (25)

1. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diab. Care 21 9 (1998) 1414-1431
2. Pyorala K., Laakso M., and Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 3 2 (1987) 463-524
3. Hu F.B., Stampfer M.J., Solomon C.G., Liu S., Willett W.C., Speizer F.E., et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med 161 14 (2001) 1717-1723
4. American Diabetes Association. Diab. Care 21 (1998) s45-s46
5. Buse J.B., Ginsberg H.N., Bakris G.L., Clark N.G., Costa F., Eckel R., et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 115 1 (2007) 114-126
6. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 7329 (2002) 71-86
7. Sacco M., Pellegrini F., Roncaglioni M.C., Avanzini F., Tognoni G., and Nicolucci A. Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diab. Care 26 12 (2003) 3264-3272
8. Ridker P.M., Cook N.R., Lee I.M., Gordon D., Gaziano J.M., Manson J.E., et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 352 13 (2005) 1293-1304
9. Ogawa H., Nakayama M., Morimoto T., Uemura S., Kanauchi M., Doi N., et al. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA 300 18 (2008) 2134-2141
10. De Berardis G., Sacco M., Strippoli G.F., Pellegrini F., Graziano G., Tognoni G., et al. Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. BMJ 339 (2009) b4531
11. Nicolucci A. Aspirin for primary prevention of cardiovascular events in diabetes: still an open question. JAMA 300 18 (2008) 2180-2181
12. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 348 9038 (1996) 1329-1339
13. Baigent C., Blackwell L., Collins R., Emberson J., Godwin J., Peto R., et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373 9678 (2009) 1849-1860
14. Belch J., MacCuish A., Campbell I., Cobbe S., Taylor R., Prescott R., et al. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 337 (2008) a1840
15. Angiolillo D.J. Variability in responsiveness to oral antiplatelet therapy. Am J Cardiol 103 3 Suppl (2009) 27A-34A
16. Diener H.C., Bogousslavsky J., Brass L.M., Cimminiello C., Csiba L., Kaste M., et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 364 9431 (2004) 331-337
17. Bhatt D.L., Fox K.A., Hacke W., Berger P.B., Black H.R., Boden W.E., et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354 16 (2006) 1706-1717
18. Wiviott S.D., Braunwald E., Angiolillo D.J., Meisel S., Dalby A.J., Verheugt F.W., et al. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38. Circulation 118 16 (2008) 1626-1636
19. Gresele P., Deckmyn H., Arnout J., Nenci G.G., and Vermylen J. Characterization of N, N′-bis(3-picolyl)-4-methoxy-isophtalamide (picotamide) as a dual thromboxane synthase inhibitor/thromboxane A2 receptor antagonist in human platelets. Thromb Haemost 61 3 (1989) 479-484
20. Neri Serneri G.G., Coccheri S., Marubini E., and Violi F. Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study. Eur Heart J 25 20 (2004) 1845-1852
21. Franchini M., and Mannucci P.M. A new era for anticoagulants. Eur J Intern Med 20 6 (2009) 562-568
22. Franchini M., and Mannucci P.M. New antiplatelet agents: why they are needed. Eur J Intern Med 20 8 (2009) 733-738
23. De Berardis G., Sacco M., Evangelista V., Filippi A., Giorda C.B., Tognoni G., et al. Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins. Trials 8 (2007) 21
24. A Study of Cardiovscular Events in Diabetes (ASCEND) Study (2008). www.ctsu.ox.ac.uk/ascend
25. Bhattacharyya O.K., Shah B.R., and Booth G.L. Management of cardiovascular disease in patients with diabetes: the 2008 Canadian Diabetes Association guidelines. CMAJ 179 9 (2008) 920-926